As the clock winds down on 2024, we at CGT Global want to take a moment to reflect and express our heartfelt gratitude to all of you — our partners, colleagues, and the global community advancing the field of cell and gene therapy. Together, we've made strides in innovation, collaboration, and care that inspire hope for a healthier future. Whether you're in the lab, at the bedside, or building the infrastructure that makes this work a reality, you’re an integral part of this transformative journey. In 2025 let’s continue to pioneer breakthroughs that change lives and rewrite what’s possible in healthcare. From all of us at CGT Global, we wish you a year filled with success, collaboration, and meaningful progress. Let’s make 2025 extraordinary — together. 𝐇𝐞𝐫𝐞’𝐬 𝐭𝐨 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧. 𝐇𝐞𝐫𝐞’𝐬 𝐭𝐨 𝐢𝐦𝐩𝐚𝐜𝐭. 𝐇𝐞𝐫𝐞’𝐬 𝐭𝐨 𝐲𝐨𝐮. Happy New Year!
CGT Global
Biotechnology Research
Folsom, CA 4,624 followers
Transforming healthcare by innovating treatment development and delivery.
About us
For nearly two decades CGT Global has pursued our mission to transform healthcare. We accelerate cell and gene therapy research and clinical trials, we streamline the commercialization of new treatments, and now, we are traversing the last mile to patient access to life-changing remedies. Accelerating Research and Clinical Trials: CGT Global is a leading manufacturer of fresh and cryopreserved human primary cells, bone marrow, cord blood, peripheral blood and disease state products. With a national footprint of CGT Clinics and Laboratories, a worldwide distribution network and over 40 partner hospitals across the United States, CGT Global is uniquely aligned for solutions and scalability. Our huge national pool of highly vetted, diverse, and recallable donors supports the most exacting research and clinical trial requirements. Streamlining the Commercialization of New Treatments Efficiently scaling newly approved and commercialized cell and gene therapies is a huge challenge to equitable healthcare worldwide. We support patients from regional healthcare facilities and directly from pharmaceutical companies by manufacturing and administering therapies and managing logistics -- from cell collection, modification, expansion and infusion for both autologous and allogeneic therapies. Traversing The Last Mile To The Patient Administering cell and gene therapies requires specialized regulatory compliance, specific certifications, focused patient collection and treatment facilities, costly logistical capabilities, and precise training for staff. Taken all together, the ability to collect, modify, store and infuse in the same facility is an enormous and crucial step in traversing the last mile to patient access. We are proud of our mission. By innovating each stage of the treatment development and delivery cycle, CGT Global gives precious months and years back to those facing serious medical conditions. #celltherapy #genetherapy #primarycells #immunotherapy
- Website
-
http://www.cgt.global
External link for CGT Global
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Folsom, CA
- Type
- Privately Held
- Founded
- 2010
- Specialties
- Cell separation and isolation, Full laboratory services, Leukopaks, Bone Marrow collection and processing, Peripheral blood collection and processing, Immunophenotyping, Human primary cells, Customized projects, Mobilized Leukopaks, Contract Research Organization, Immune cells, cGTP & cGMP compliant, Procurement, Biospecimen, Stem Cells, Mesenchymal, Donor recruitment, Donor Recruitment, Bulk Cell Isolation, Apheresis, PBMCs, Cord Blood Collection & Processing, Primary Cell separation and isolation, Fresh and Cryopreserved Human primary cells, Disease state blood collection and processing, GMP Leukopaks, Customized scalable projects , and Bulk Cell Isolation
Locations
Employees at CGT Global
Updates
-
"Hi there! It’s your favorite lab elves, back with another holiday research gift! This time, we’re spotlighting the immune system’s cleanup crew and communication experts—𝐌𝐨𝐧𝐨𝐜𝐲𝐭𝐞-𝐃𝐞𝐫𝐢𝐯𝐞𝐝 𝐌𝐚𝐜𝐫𝐨𝐩𝐡𝐚𝐠𝐞𝐬 (𝐌𝐃𝐌𝐬)! 🧪🧝♂️ When tissue damage or infection strikes, 𝐦𝐨𝐧𝐨𝐜𝐲𝐭𝐞𝐬 step up, transforming into 𝐦𝐚𝐜𝐫𝐨𝐩𝐡𝐚𝐠𝐞𝐬, the ultimate defenders of 𝐢𝐧𝐧𝐚𝐭𝐞 𝐢𝐦𝐦𝐮𝐧𝐢𝐭𝐲. These specialized cells are incredibly versatile, adapting their functional phenotype based on the invaders they encounter. ✨ 𝐖𝐡𝐚𝐭 𝐌𝐚𝐤𝐞𝐬 𝐌𝐚𝐜𝐫𝐨𝐩𝐡𝐚𝐠𝐞𝐬 𝐒𝐨 𝐒𝐩𝐞𝐜𝐢𝐚𝐥? 🔬 𝐏𝐚𝐭𝐡𝐨𝐠𝐞𝐧 𝐂𝐥𝐞𝐚𝐫𝐚𝐧𝐜𝐞: They recognize, engulf, and destroy target cells and pathogens. 🧬 𝐈𝐦𝐦𝐮𝐧𝐞 𝐂𝐨𝐦𝐦𝐮𝐧𝐢𝐜𝐚𝐭𝐢𝐨𝐧: Acting as antigen-presenting cells (APCs), they instruct other immune cells to join the response. ❄️ 𝐖𝐡𝐲 𝐂𝐡𝐨𝐨𝐬𝐞 𝐌𝐨𝐧𝐨𝐜𝐲𝐭𝐞-𝐃𝐞𝐫𝐢𝐯𝐞𝐝 𝐌𝐚𝐜𝐫𝐨𝐩𝐡𝐚𝐠𝐞𝐬? Isolating mature macrophages directly from tissue can be tricky, but we’ve got a better way! Our 𝐌𝐃𝐌𝐬 are derived from purified CD14+ monocytes, untouched and ready for action: ✔️ 𝐏𝐮𝐫𝐢𝐟𝐢𝐜𝐚𝐭𝐢𝐨𝐧: Non-monocytes are depleted using immunomagnetic particles for unmatched precision. ✔️ 𝐂𝐮𝐥𝐭𝐮𝐫𝐢𝐧𝐠 𝐄𝐱𝐜𝐞𝐥𝐥𝐞𝐧𝐜𝐞: CD14+ monocytes are cultured for 4-5 days with 𝟏𝟎% 𝐅𝐁𝐒, 𝐌-𝐂𝐒𝐅, and 𝐈𝐋-𝟒 to create functional macrophages. ✔️ 𝐑𝐢𝐠𝐨𝐫𝐨𝐮𝐬 𝐓𝐞𝐬𝐭𝐢𝐧𝐠: Cells are checked for markers like 𝐂𝐃𝟏𝟏𝐛, 𝐂𝐃𝟏𝟖, 𝐂𝐃𝟔𝟖, 𝐚𝐧𝐝 𝐇𝐋𝐀-𝐃𝐑 using flow cytometry. Whether you’re studying pathogen clearance, immune modulation, or APC function, our 𝐌𝐃𝐌𝐬 are ready to make your research extraordinary. 🎁🔬 Email us at orders@cgt.global with the code “LINK-CELEBRATION” to secure your cells today!
-
-
🎁 "The elves have a special gift for you today—meet 𝐂𝐃𝟖+ 𝐂𝐲𝐭𝐨𝐭𝐨𝐱𝐢𝐜 𝐓 𝐂𝐞𝐥𝐥𝐬, the brave sentinels of the immune system! 💥🧪" These remarkable cells are the body’s frontline defense against 𝐢𝐧𝐭𝐫𝐚𝐜𝐞𝐥𝐥𝐮𝐥𝐚𝐫 𝐩𝐚𝐭𝐡𝐨𝐠𝐞𝐧𝐬 like viruses 🦠 and bacteria 🧬, as well as 𝐜𝐚𝐧𝐜𝐞𝐫𝐨𝐮𝐬 𝐜𝐞𝐥𝐥𝐬. Their mission? To seek, recognize, and destroy infected or diseased cells while leaving healthy ones unharmed. ✨ 𝐇𝐨𝐰 𝐃𝐨 𝐂𝐃𝟖+ 𝐓 𝐂𝐞𝐥𝐥𝐬 𝐖𝐨𝐫𝐤 𝐓𝐡𝐞𝐢𝐫 𝐌𝐚𝐠𝐢𝐜? 🔍 𝐏𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐑𝐞𝐜𝐨𝐠𝐧𝐢𝐭𝐢𝐨𝐧: They identify infected or diseased cells by detecting antigens presented by MHC class I molecules on the cell surface. 💥 𝐂𝐲𝐭𝐨𝐭𝐨𝐱𝐢𝐜 𝐏𝐨𝐰𝐞𝐫: Upon recognizing a target, CD8+ T cells release cytotoxins that trigger apoptosis, eliminating the threat. ❄️ 𝐖𝐡𝐲 𝐂𝐡𝐨𝐨𝐬𝐞 𝐎𝐮𝐫 𝐂𝐃𝟖+ 𝐓 𝐂𝐞𝐥𝐥𝐬? ✔️ 𝐏𝐮𝐫𝐢𝐭𝐲 𝐆𝐮𝐚𝐫𝐚𝐧𝐭𝐞𝐞𝐝: Isolated using negative selection, ensuring untouched, high-quality cells for your research. ✔️ 𝐈𝐦𝐦𝐮𝐧𝐞 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐚𝐝𝐲: Perfect for studying adaptive immunity, cellular interactions, and therapeutic development. These immune champions are ready to join your lab’s fight against disease and support groundbreaking discoveries. Don’t let this holiday season pass without adding them to your research toolbox! 🎁🔬 Email us at orders@cgt.global with the code “LINK-CELEBRATION” to secure your cells today!
-
-
Greetings from the lab! We've been working overtime (with plenty of cocoa breaks) to bring you the gift of discovery this holiday season! 🎁 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐢𝐧𝐠 𝐭𝐡𝐞 𝐒𝐭𝐚𝐫 𝐨𝐟 𝐭𝐡𝐞 𝐒𝐞𝐚𝐬𝐨𝐧: 𝐏𝐞𝐫𝐢𝐩𝐡𝐞𝐫𝐚𝐥 𝐁𝐥𝐨𝐨𝐝 𝐌𝐨𝐧𝐨𝐧𝐮𝐜𝐥𝐞𝐚𝐫 𝐂𝐞𝐥𝐥𝐬 (𝐏𝐁𝐌𝐂𝐬) PBMCs, originating from 𝐡𝐞𝐦𝐚𝐭𝐨𝐩𝐨𝐢𝐞𝐭𝐢𝐜 𝐬𝐭𝐞𝐦 𝐜𝐞𝐥𝐥𝐬 (𝐇𝐒𝐂𝐬) in the bone marrow, are a powerful resource for immune research and therapies. These cells are critical players in the immune system, comprising of: 🔹 𝐓 𝐂𝐞𝐥𝐥𝐬, 𝐁 𝐂𝐞𝐥𝐥𝐬, 𝐚𝐧𝐝 𝐍𝐊 𝐂𝐞𝐥𝐥𝐬 for adaptive and innate responses. 🔹 𝐃𝐞𝐧𝐝𝐫𝐢𝐭𝐢𝐜 𝐂𝐞𝐥𝐥𝐬 for antigen presentation. 🔹 𝐌𝐨𝐧𝐨𝐜𝐲𝐭𝐞𝐬 for phagocytosis and signaling. Did you know? 𝟕𝟎-𝟗𝟎% 𝐨𝐟 𝐏𝐁𝐌𝐂𝐬 𝐚𝐫𝐞 𝐥𝐲𝐦𝐩𝐡𝐨𝐜𝐲𝐭𝐞𝐬, the vital architects of cell-mediated and humoral immune defenses. ⏳ 𝐓𝐢𝐦𝐞 𝐢𝐬 𝐫𝐮𝐧𝐧𝐢𝐧𝐠 𝐨𝐮𝐭! Order now to take advantage of this festive offer and unwrap the magic of PBMCs for your next breakthrough. Email us at orders@cgt.global with the code “LINK-CELEBRATION” to secure your cells today!
-
-
🎄 While the holiday spirit is buzzing, so are our centrifuges and cryo tanks! We are thrilled to introduce a true star of the immune system—𝐇𝐮𝐦𝐚𝐧 𝐂𝐃𝟒+ 𝐇𝐞𝐥𝐩𝐞𝐫 𝐓 𝐂𝐞𝐥𝐥𝐬! These little powerhouses are like the ultimate lab assistants (besides us, of course ), coordinating immune responses and making scientific magic happen. CD4+ helper T cells are activated when they are presented with an antigen on the MHC class II molecule of an antigen-presenting cell (APC). Once activated, 𝐂𝐃𝟒+ 𝐡𝐞𝐥𝐩𝐞𝐫 𝐓 𝐜𝐞𝐥𝐥𝐬 secrete lymphokines that assist in the activation of B cells to secrete antibodies that target specific microbes and assist in the activation of cytotoxic T cells to destroy infected target cells. These cells are carefully isolated from peripheral blood in our laboratory using negative selection techniques. Our extensive inventory offers a wide range of high-quality cryopreserved cells to meet your research needs. ⏳ 𝐓𝐢𝐦𝐞 𝐢𝐬 𝐫𝐮𝐧𝐧𝐢𝐧𝐠 𝐨𝐮𝐭! Order now to take advantage of this festive offer and unwrap the magic of CD4+’s for your next breakthrough. Email us at orders@cgt.global with the code “LINK-CELEBRATION” to secure your cells today!
-
-
It has been a great pleasure meeting and attending presentations from physicians, academics, and industry leaders worldwide! The ASH (American Society of Hematology) conference has been an incredible opportunity for the CGT Global team to connect, learn, and grow. We’ve been inspired by the groundbreaking advancements in hematology and the passion shared by professionals from around the globe. From innovative gene therapies to cutting-edge cell-based treatments, the insights and collaborations formed here are paving the way for new milestones in healthcare. A big thank you to the organizers, speakers, and participants for creating such a vibrant and impactful event. Together, we are shaping the future of medicine! #CGTGlobal #ASH2024 #Hematology #GeneTherapy #CellTherapy #Collaboration #Innovation
-
-
We’re thrilled to introduce our team attending American Society of Hematology Conference! Our Founder & CEO, Cate Dyer Spears, Process Development Scientist Eliona Kola, and Medical Director Andrew Branagan, M.D., Ph.D., are excited to connect, share insights, and collaborate with industry leaders. Don’t miss the opportunity to reach out and explore potential partnerships with us! #AmericanSocietyofHematology #ASH24 #Research #CellTherapy #CGTGlobal #Innovation
-
-
Harness the natural defense mechanism of 𝐂𝐃𝟓𝟔+ 𝐍𝐚𝐭𝐮𝐫𝐚𝐥 𝐊𝐢𝐥𝐥𝐞𝐫 (𝐍𝐊) 𝐂𝐞𝐥𝐥𝐬—your immune system's frontline against infections and malignancies. CGT Global’s CD56+ cells are enriched via 𝐧𝐞𝐠𝐚𝐭𝐢𝐯𝐞 𝐬𝐞𝐥𝐞𝐜𝐭𝐢𝐨𝐧 from human peripheral blood. The elves are offering 30% off our extensive NK CD56+ inventory for any shipment until the end of the year! Contact us to learn more or place your order today. - Prefer 𝐩𝐨𝐬𝐢𝐭𝐢𝐯𝐞 𝐬𝐞𝐥𝐞𝐜𝐭𝐢𝐨𝐧? We offer this as a custom order to meet your specific needs. 🎁 𝐓𝐡𝐢𝐬 𝐡𝐨𝐥𝐢𝐝𝐚𝐲, 𝐥𝐞𝐭 𝐬𝐜𝐢𝐞𝐧𝐜𝐞 𝐬𝐡𝐢𝐧𝐞 𝐛𝐫𝐢𝐠𝐡𝐭𝐞𝐫! Email us at orders@cgt.global with the code “LINK-CELEBRATION” to secure your cells today! #CD56 #NaturalKillerCells #Immunology #ResearchScience
-
-
Celebrate the holidays by fueling groundbreaking research with our 𝐂𝐨𝐫𝐝 𝐁𝐥𝐨𝐨𝐝 𝐂𝐃𝟑𝟒+ 𝐒𝐭𝐞𝐦 𝐚𝐧𝐝 𝐏𝐫𝐨𝐠𝐞𝐧𝐢𝐭𝐨𝐫 𝐂𝐞𝐥𝐥𝐬—the foundation of the immune system. - 𝐏𝐨𝐬𝐢𝐭𝐢𝐯𝐞𝐥𝐲 𝐬𝐞𝐥𝐞𝐜𝐭𝐞𝐝 using immunomagnetic anti-CD34 (clone QBEND10) microbeads from the mononuclear cell fraction and offered in 𝐩𝐚𝐢𝐫𝐞𝐝 𝐟𝐨𝐫𝐦𝐚𝐭𝐬 with 𝐂𝐨𝐫𝐝 𝐁𝐥𝐨𝐨𝐝 𝐂𝐃𝟑𝟒- 𝐌𝐍𝐂𝐬 for added research flexibility, our primary cells enable you to have the highest HIS mice engraftment rates! 📋 𝐒𝐩𝐞𝐜𝐢𝐚𝐥 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐬: - Low Res HLA Typing by Flow - 𝐋𝐂𝐌𝐕 𝐭𝐞𝐬𝐭𝐢𝐧𝐠 available for most inventory. 🎄 Let’s make your research goals a reality! Email us at orders@cgt.global with the code “LINK-CELEBRATION” to secure your cells today! #CordBlood #CD34StemCells #Hematopoiesis #ImmuneResearch #HolidayScience
-
-
🎄🔬𝐓𝐡𝐢𝐬 𝐇𝐨𝐥𝐢𝐝𝐚𝐲 𝐒𝐞𝐚𝐬𝐨𝐧 𝐂𝐃𝟏𝟒+ 𝐌𝐨𝐧𝐨𝐜𝐲𝐭𝐞𝐬 𝐟𝐨𝐫 𝐘𝐨𝐮𝐫 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡! 🎁🧪 Support your research with 𝐂𝐃𝟏𝟒+ 𝐏𝐞𝐫𝐢𝐩𝐡𝐞𝐫𝐚𝐥 𝐁𝐥𝐨𝐨𝐝 𝐌𝐨𝐧𝐨𝐜𝐲𝐭𝐞𝐬—the immune system's frontline defenders! - Originating in the 𝐁𝐨𝐧𝐞 𝐌𝐚𝐫𝐫𝐨𝐰, these monocytes travel via the bloodstream to 𝐢𝐧𝐟𝐞𝐜𝐭𝐞𝐝 𝐨𝐫 𝐝𝐚𝐦𝐚𝐠𝐞𝐝 𝐭𝐢𝐬𝐬𝐮𝐞𝐬, where they transform into tissue macrophages or dendritic cells. 🔧 𝐇𝐨𝐰 𝐰𝐞 𝐩𝐫𝐞𝐩𝐚𝐫𝐞 𝐭𝐡𝐞𝐦: - Isolated at 𝐂𝐆𝐓 𝐆𝐥𝐨𝐛𝐚𝐥 by 𝐧𝐞𝐠𝐚𝐭𝐢𝐯𝐞 𝐬𝐞𝐥𝐞𝐜𝐭𝐢𝐨𝐧. - Prefer 𝐩𝐨𝐬𝐢𝐭𝐢𝐯𝐞 𝐬𝐞𝐥𝐞𝐜𝐭𝐢𝐨𝐧? We offer this as a custom order! - 𝐀𝐥𝐥 𝐂𝐃𝟏𝟒 𝐢𝐧𝐯𝐞𝐧𝐭𝐨𝐫𝐲 𝐚𝐯𝐚𝐢𝐥𝐚𝐛𝐥𝐞 𝐚𝐭 𝐬𝐩𝐞𝐜𝐢𝐚𝐥 𝐡𝐨𝐥𝐢𝐝𝐚𝐲 𝐩𝐫𝐢𝐜𝐢𝐧𝐠—ready to meet your research needs. Let’s advance science together—one breakthrough at a time. Email us at orders@cgt.global with the code “LINK-CELEBRATION” to secure your cells today! #CD14 #Monocytes #StemCellResearch #Immunology #CGTGlobal
-